Induction of apoptosis and transient increase of phosphorylated MAPKs by diallyl disulfide treatment in human nasopharyngeal carcinoma CNE2 cells

Archives of Pharmacal Research

Volumn 29, Issue 12, 2006, Pages 1125-1131

  Yi, Wei Zhang ^a   Wen, Jun ^a   Jian, Bo Xiao ^a   Talbot, Simon G ^b   Li, Gloria C ^b   Xu, Ming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Anticancer effect; Apoptosis; cell cycle; Diallyl disulfide (DADS); Human nasopharyngeal carcinoma CNE2 cells; Phosphorylated MAPKs

Indexed keywords

EID: 33845993246     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02969303     Document Type: Article

References (39)

1. Amato, S. F., Swart, J. M., Berg, M., Wanebo, H. J., Mehta, S. R., and Chiles, T. C., Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res., 58, 241-247 (1998).
2. Bates, R. C., Buret, A., van Helden, D. F., Horton, M. A., and Burns, G. F., Apoptosis induced by inhibition of intercellular contact. J. Cell Biol., 12, 403-415 (1994).
3. Berra, E., Diaz-Meco, M. T., and Moscat, J., The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J. Biol. Chem., 273, 10792-10797 (1998).
4. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., and Greenberg, M.E., Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science, 286, 1358-1362 (1999).
5. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
6. Dent, P., Jarvis, W. D., Birrer, M. J., Fisher, P. B., Schmidt-Ullrich, R. K., and Grant, S., The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity. Leukemia, 12, 1843-1850 (1998).
7. Farrow, S. N. and Brown, R., New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev., 6, 45-49 (1996).
8. Filomeni, G., Aquilano, K., Rotilio, G., and Ciriolo, M. R., Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res., 63, 5940-5949 (2003).
9. Flamigni, F., Facchini, A., Stanic, I., Tantini, B., Bonavita, F., and Stefanelli, C., Control of survival of proliferating L1210 cells by soluble guanylate cyclase and p44/42 mitogen-activated protein kinase modulators. Biochem. Pharmacol., 62, 319-328 (2001).
10. Hansen, M. B., Nielsen, S. E., and Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119, 203-210 (1989).
11. Hong, Y. S., Ham, Y. A., Choi, J. H., and Kim, J., Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp. Mol. Med., 32, 127-134 (2000).
12. Huang, Y., Sheikh, M. S., Fornace, A. J. Jr., and Holbrook, N. J., Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells. Oncogene, 18, 3431-3439 (1999).
13. Iwai-Kanai, E., Hasegawa, K., Fujita, M., Araki, M., Yanazume, T., Adachi, S., and Sasayama, S., Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J. Cell Physiol., 190, 54-62 (2002).
14. Knowles, L. M. and Milner, J. A., Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells. J. Nutr., 133, 2901-2906 (2003).
15. Knowles, L. M. and Milner, J.A., Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr. Cancer, 30, 169-174 (1998).
16. Kolb, J. P., Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia, 14, 1685-1694 (2000).
17. Kroemer, G., The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med., 3, 614-620 (1997).
18. Kwon, K. B., Yoo, S. J., Ryu, D. G., Yang, J. Y., Rho, H. W., and Kim, J. S., Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem. Pharmacol., 63, 41-47 (2002).
19. Robert, V., Mouille, B., Mayeur, C., Michaud, M., and Blachier, F., Effects of the garlic compound diallyl disulfide on the metabolism, adherence and cell cycle of HT-29 colon carcinoma cells: evidence of sensitive and resistant subpopulations. Carcinogenesis, 22, 1155-1161 (2001).
20. Lea, M. A. and Ayyala, U. S., Differentiating and growth inhibitory effects of diallyl disulfide on cancer cells. Int. J. Oncol., 11, 181-186. (1997).
21. Lee, L. F., Li, G., Templeton, D. J., and Ting, J. P., Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J. Biol. Chem., 273, 28253-28260 (1998).
22. Lieu, C. H., Liu, C. C., Yu, T. H., Chen, K. D., Chang, Y. N., and Lai, Y. K., Role of mitogen-activated protein kinase in Taxol-induced apoptosis in human leukemic U937 cells. Cell Growth Differ., 9, 767-776 (1998).
23. McDaid, H. M. and Horwitz, S. B., Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol. Pharmacol., 60, 290-301 (2001).
24. Meinhardt, G., Wendtner, C. M., and Hallek, M., Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J. Mol. Med., 77, 282-293 (1999).
25. Mendelson, K. G., Contois, L. R., Tevosian, S. G., Davis, R. J., and Paulson, K. E., Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. U.S.A., 93, 12908-12913 (1996).
26. Nakagawa, H., Tsuta, K., Kiuchi, K., Senzaki, H., Tanaka, K., and Hioki, K., Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis, 22, 891-897 (2001).
27. Niisato, N., Post, M., Van Driessche, W., and Marunaka, Y., Cell swelling activates stress-activated protein kinases, p38 MAP kinase and JNK, in renal epithelial A6 cells. Biochem. Biophys. Res. Commun., 266, 547-250 (1999).
28. Pouyssegur, J. and Lenormand, P., Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur. J. Biochem., 270, 3291-3299 (2003).
29. Shtil, A. A., Mandlekar, S., Yu, R., Walter, R. J., Hagen, K., Tan, T. H., Roninson, I. B., and Kong, A. N., Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene, 18, 377-338 (19994).
30. Stone, A. A. and Chambers, T. C., Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res., 254, 110-119 (2000).
31. Sundaram, S. G. and Milner, J. A., Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis, 17, 669-673 (1996).
32. Thornberry, N. A. and Lazebnik, Y., Caspases: enemies within. Science, 281, 1312-1316 (1998).
33. Vinals, F. and Pouyssegur, J., Transforming growth factor 1 (TGF-1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol. Cell Biol., 21, 7218-7230 (2001).
34. Wang, T. H., Popp, D. M., Wang, H. S., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H., and Wimalasena, J., Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J. Biol. Chem., 274, 8208-8216 (1999).
35. Wang, T. H., Wang, H. S., Ichijo, H., Giannakakou, P., Foster, J. S., Fojo, T., and Wimalasena, J., Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem., 273, 4928-4936 (1998).
36. Wen, J., Zhang, Y. W., Chen, X. Q., Shen, L. B., Li, G. C., and Xu, M., Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells. Biochem. Pharmacol., 68, 323-331 (2004).
37. Widmann, C., Gibson, S., Jarpe, M. B., and Johnson, G. L., Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev., 79, 143-180 (1999).
38. Yujiri, T., Fanger, G. R., Garrington, T. P., Schlesinger, T. K., Gibson, S., and Johnson, G. L., MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton. J. Biol. Chem., 274, 12605-2610 (1999).
39. Yujiri, T., Sather, S., Fanger, G. R., and Johnson, G. L., Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science, 282, 1911-1914 (1998).